Featured Research

from universities, journals, and other organizations

Clues to finding further causes for monogenic diabetes

Date:
September 21, 2011
Source:
Elhuyar Fundazioa
Summary:
In most cases of diabetes, various genes and environmental factors are involved. Not in monogenic diabetes, where the causes are mutations in just a single gene. Between 25% and 45% of family members or patients with monogenic diabetes do not present alterations in any of the genes that have been put forward to date as possible causes, and so new candidate genes have had to be identified. A biochemist in Spain has discovered that the 8p12-p11 chromosome region could host a gene responsible for this rare disease.

In most cases of diabetes, various genes and environmental factors are involved. Not in monogenic diabetes, where the causes are mutations in just a single gene. Between 25% and 45% of family members or patients with monogenic diabetes do not present alterations in any of the genes that have been put forward to date as possible causes, and so new candidate genes have had to be identified.

Biochemist Ms Intza Garin has made advances in this direction, in a thesis defended at the University of the Basque Country (UPV/EHU) and entitled "The search for new genes involved in monogenic diabetes." The research by her work team has also been reflected in publications such as The Journal of Clinical Endocrinology & Metabolism, in December 2010.

Monogenic diabetes is considered a rare disease, making up only 1% to 3% of all cases of diabetes. There are two types: neonatal and Maturity Onset Diabetes of the Young (MODY). In most cases, it is a hereditary disease that appears when one of the parents passes on the mutation in one of their genes to their offspring, although there are also cases in which such a mutation is generated spontaneously. Garin believes that these alterations may be produced in genes that have not been associated with this type of diabetes to date. Thus, she set out to identify hitherto unknown causes to the disease by studying affected families and patients.

Chromosome 8 and more clues

Garin carried out an analysis of the complete genome, while not prove useful in determining which new genes might be responsible for monogenic diabetes, was able to throw light on chromosome 8. Although the search for mutations here did not conclude with the discovery of a causal genetic variant, the data obtained confirm that the 8p12-p11 region of this chromosome is a candidate for being a gene responsible for this rare disease.

As a consequence, Garin's thesis may well be a new, hitherto unknown, starting point in the quest for the causes of monogenic diabetes. The research also came up with other clues which could help with future studies.

Concretely, the researcher stressed in her research that the analysis should not be only focused on the analysis of the codifying region of the gene, but should include the non-codifying regions (introns and 5' and 3' UTR regions), given that variants were also observed in these zones. Likewise, Garin recommends analysing the possible alterations as regards the number of copies of the sequence, because, despite it not having been the case in this research in concrete, it may well be an indicator when studying other candidate regions. Finally, as regards neonatal diabetes, the evidence points to the age of diagnosis, the weight at birth, the ponderal index and the permanent or transitory form of the diabetes as being pointers in the genetic study of the ailment.


Story Source:

The above story is based on materials provided by Elhuyar Fundazioa. Note: Materials may be edited for content and length.


Journal Reference:

  1. Q. Zhou, I. Garin, L. Castano, J. Argente, M. T. Munoz-Calvo, G. Perez de Nanclares, S.-L. Shyng. Neonatal Diabetes Caused by Mutations in Sulfonylurea Receptor 1: Interplay between Expression and Mg-Nucleotide Gating Defects of ATP-Sensitive Potassium Channels. Journal of Clinical Endocrinology & Metabolism, 2010; 95 (12): E473 DOI: 10.1210/jc.2010-1231

Cite This Page:

Elhuyar Fundazioa. "Clues to finding further causes for monogenic diabetes." ScienceDaily. ScienceDaily, 21 September 2011. <www.sciencedaily.com/releases/2011/09/110921074734.htm>.
Elhuyar Fundazioa. (2011, September 21). Clues to finding further causes for monogenic diabetes. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2011/09/110921074734.htm
Elhuyar Fundazioa. "Clues to finding further causes for monogenic diabetes." ScienceDaily. www.sciencedaily.com/releases/2011/09/110921074734.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins